In all cases, liver-specific (ASGR1+) EV-derived miRNA biomarkers demonstrated strong capacity to predict subject status as the control, NAFL, or NASH (Figure 5) with c-statistics > 0.78. Here, ASGR1 is linked to metabolic dysfunction-associated steatohepatitis.